VIRTUAL

Priorities for Long Covid services, care and research

Virtual

31 January 2023

event details 

Genomics England research seminar

Virtual

31 January 2023

event details 

NORTH AMERICA

Annual Sachs Neuroscience Innovation Forum

San Francisco, California

8 January 2023

event details 

Needham Growth Conference

New York, New York

10-12 January 2023

event details 

Annual JP Morgan Health Care Conference

San Francisco, California

9-12 January 2023

event details 

ASCO Gastrointestinal Cancers Symposium

San Francisco, California/ Online

19-21 January 2023

event details 

SOUTH AMERICA

American Society of Clinical Oncology 

Chicago, Illinois 

3-7 June  2022

event details 

Outsourcing in Clinical Trials: Medical Devices USA 2022 

Irvine, California 

8-9 June 2022

event details 

EUROPE

Digital Pharma Advances Conference

London, UK

31 January 2023

event details 

MIDDLE EAST

Outsourcing in Clinical Trials & Clinical Trial Supply Israel

Tel Aviv, Israel

6-7 February 2023 

event details 

ASIA PACIFIC

Outsourcing in Clinical Trials & Clinical Trial Supply Israel

Souel, South Korea

6-7 February 2023 

event details 

Go to article: Home | Biosimilars set the stageGo to article: In this issueGo to article: ContentsGo to article: CSafeAPSGo to article: Mimotopes Company Insight Go to article: BriefingGo to article: Industry newsGo to article: The pharma industry briefingGo to article: TripletreeGo to article: CommentGo to article: Cannabinoids receptors: popular preclinical target but banned in 137 countriesGo to article: Ozempic compensating for Wegovy’s supply shortage due to high demandGo to article: Manufacturing challenges set back progress of cell therapies in oncologyGo to article: Chinese transition to innovative pharma needs more investmentGo to article: DLBCL: a rapidly evolving treatment landscape with a crowded pipelineGo to article: Bio Image Systems Inc.Go to article: In DepthGo to article: Humira biosimilars set the stage for long-awaited 2023 US launchesGo to article: Expanding ketamine’s horizons for rare neurological disordersGo to article: The “Medical Bypass”: New drugs to strike obesityGo to article: Running low on comparators: drug shortages in oncology clinical trialsGo to article: ACT EU state of play: EMA’s headway to transform clinical trialsGo to article: CMO Moves: Regulatory catalysts for drug manufacturing-DecemberGo to article: EventsGo to article: Next issue